Hannah Joseph Hospital Ltd IPO
Healthcare
Price Band
₹67 – ₹70
Lot Size
2000
Minimum Bid Quantity
4000
Minimum Investment
₹280000
Issue Size
₹42Cr
Opens
2026-01-22
Closes
2026-01-28
Listing
02-02-2026
Subscription Status
Qualified Institutional Buyers
1.08 x
Non-Institutional Investor
1.72 x
Retail Individual Investor
1.62 x
Total
1.5 x
IPO Details
Issue Type
FP
Face Value
₹10
Tick Size
1
ISIN
INE0JVH01012
Pre-Apply Available
No
Daily Bidding Time
10:00:00 - 17:00:00
About the Company
Hannah Joseph Hospital Limited is a multi-speciality hospital in Madurai, Tamil Nadu, focused on neurology and neurosurgery. It was started in 2008 as a sole proprietorship by neurosurgeon Mosesjoseph Arunkumar, incorporated as a private limited company in 2011, and converted to a public limited company in 2022. The hospital provides services in neurology, cardiology, psychiatry, and trauma care. It includes a neuroradiology department and cardiac sciences facilities with a cath lab and cardiac surgery theatres, and performs coronary angioplasties and open-heart surgeries. The hospital operates from a two-acre campus in Madurai, with a combined bed capacity of 150 beds
Pros
- • Hannah Joseph Hospital claims to have a strong focus on neurosciences, covering neurosurgery, neurology, and neurointerventional radiology. It states that it handles complex brain and spinal procedures and undertakes minimally invasive neurological interventions such as aneurysm coiling and stroke-related procedures.
- • The hospital claims to offer diagnostic services such as MRI, CT scans, and EEGs for neurological conditions. It also states that it follows defined treatment and rehabilitation protocols for disorders, including epilepsy, stroke, and neurodegenerative diseases.
- • Hannah Joseph Hospital claims to provide 24/7 emergency services and critical care support. It states that its intensive care units are equipped to manage patients requiring advanced monitoring and ventilatory support through a multidisciplinary approach.
Cons
- • Hannah Joseph Hospital’s revenues are significantly dependent on its only hospital in Madurai, and it derives almost all revenue from operations from this single location. Any adverse economic, political, or regional developments in or around Madurai, along with factors such as reduced patient footfall, regulatory changes, reputational harm, medical negligence-related liabilities, adverse publicity, natural calamities, or increased competition, could affect its business, financial condition, and results of operations.
- • A substantial portion of Hannah Joseph Hospital’s revenue is dependent on neurosciences, interventional neuro-radiology, trauma services, and radiology services. Any adverse change affecting these fields, such as inability to adopt modern technology, competitors implementing newer techniques, decline in new patient registrations, loss of key medical professionals, medical negligence-related liabilities, or regulatory changes, could adversely impact its business, prospects, financial condition, and results of operations.
- • In-patient admissions accounted for Rs 27.96 crore (65.72 percent) of the company’s revenue for the period ended September 30, 2025; Rs 52.09 crore (67.19 percent) in FY25; Rs 43.53 crore (68.65 percent) in FY24; and Rs 36.86 crore (67.49 percent) in FY23. Any decline in in-patient volumes, such as patients opting for competitors for admissions and treatment, could materially impair revenue growth and adversely affect its financial condition and results of operations.
Get real-time IPO alerts on WhatsApp
Opening reminders • Subscription updates • GMP alerts • Allotment results
Start WhatsApp Alerts